Study #2018-0274
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
MD Anderson Study Status
Not Accepting
Treatment Agent
ADP adoptive cell therapy
Description
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Neoplasms
Study phase:
Phase I
Physician name:
Dejka Araujo
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-833-670-2212
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.